Skopos Labs, Inc. Biotechnology

Skopos Labs, Inc.

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
XNCR Xencor Inc	$534M	$0 0.0% of portfolio	35	Q4 2024 New
PCVX Vaxcyte, Inc.	$1.9B	$0 0.0% of portfolio	10	Q4 2024 New
ROIV Roivant Sciences Ltd.	$7.18B	$0 0.0% of portfolio	4	Q4 2024 New
NRIX Nurix Therapeutics, Inc.	$464M	$0 0.0% of portfolio	35	Q4 2024 New
RCUS Arcus Biosciences, Inc.	$554M	$0 0.0% of portfolio	1	Q4 2024 New
VCEL Vericel Corp	$1.95B	$0 0.0% of portfolio	17	Q4 2024 New
ADMA Adma Biologics, Inc.	$4.11B	$0 0.0% of portfolio	9	Q4 2024 New
AUTL Autolus Therapeutics PLC	$122M	$0 0.0% of portfolio	377	Q4 2024 New
CRBU Caribou Biosciences, Inc.	$48.7M	$0 0.0% of portfolio	362	Q4 2024 New
BBIO Bridge Bio Pharma, Inc.	$5.17B	$0 0.0% of portfolio	5	Q4 2024 New
TERN Terns Pharmaceuticals, Inc.	$86.9M	$0 0.0% of portfolio	161	Q4 2024 New
YMAB Y M Abs Therapeutics, Inc.	$216M	$0 0.0% of portfolio	127	Q4 2024 New
ACLX Arcellx, Inc.	$2.66B	$0 0.0% of portfolio	7	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	47	Q4 2024 New
INZY Inozyme Pharma, Inc.	$38.9M	$0 0.0% of portfolio	314	Q4 2024 New
ORIC Oric Pharmaceuticals, Inc.	$202M	$0 0.0% of portfolio	105	Q4 2024 New
WXXWY Wuxi Biologics Cayman Inc	$14.1B	$0 0.0% of portfolio	40	Q4 2024 New

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

Stay updated on Skopos Labs, Inc. with notifications on news.